{"id":870066,"date":"2025-07-15T18:19:11","date_gmt":"2025-07-15T22:19:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"modified":"2025-07-15T18:19:11","modified_gmt":"2025-07-15T22:19:11","slug":"extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","title":{"rendered":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n SAN DIEGO<\/span>
\n <\/span>, July 15, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0Robbins Geller Rudman<\/span> & Dowd LLP<\/a><\/b> announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022<\/span> and April 30, 2025<\/span>, both dates inclusive (the “Class Period”).\u00a0 Captioned Lerner v. Organon & Co.<\/i>, No. 25-cv-12983 (D.N.J.), the Organon <\/i>class action lawsuit charges Organon as well as certain of Organon’s top executives with violations of the Securities Exchange Act of 1934.\u00a0 A previously filed complaint is captioned Hauser v. Organon & Co.<\/i>, No. 25-cv-05322 (D.N.J.).<\/p>\n

\n

\n
\n \"Robbins
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n If you suffered substantial losses and wish to serve as lead plaintiff of the Organon <\/i>class action lawsuit, please provide your information here:<\/b>\n <\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/cases-organon-co-class-action-lawsuit-ogn.html<\/a>
\n <\/b>\n <\/p>\n

\n You can also contact attorneys J.C. Sanchez<\/a> or Jennifer N. Caringal<\/span><\/a> of Robbins Geller by calling 800\/449-4900 or via e-mail at info@rgrdlaw.com<\/a>.\u00a0 Lead plaintiff motions for the Organon <\/i>class action lawsuit must be filed with the court no later than Tuesday, July 22, 2025<\/span>.<\/b>\n <\/p>\n

\n CASE ALLEGATIONS<\/b>: Organon develops and delivers health solutions through prescription therapies and medical devices.<\/p>\n

The Organon<\/i> class action lawsuit alleges<\/span> that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (i) Organon faced a higher risk of loss of exclusivity and price erosion as to Nexplanon than implied by its Class Period statements; (ii) as a result, Organon’s long-term Nexplanon sales growth was not as strong as defendants’ portended during the Class Period, and would not reach $1 billion<\/span> by the end of fiscal year 2025 (much less upwards of $1.5 billion<\/span> after that), and that Organon was likely not on track to achieve the $1 billion<\/span> milestone payment from Merck & Co. on its Nexplanon sales thereafter; (iii) thus, Organon was not on track to achieve, much less maintain, the $1 billion<\/span> in free cash flow required to sustain its outsized dividend; (iv) consequently, Organon was also not on track to maintain 4.0x debt leverage; (v) as such, Organon might not be able to maintain its corporate debt ratings at their then-current Class Period levels; and (vi) as a result, Organon lacked a reasonable basis to report its Class Period business metrics and financial projections.<\/p>\n

The Organon<\/i> class action lawsuit further alleges<\/span> that on May 1, 2025<\/span>, in connection with announcing its first quarter 2025 financial results for the interim period ended March 31, 2025<\/span>, Organon slashed its dividend by 90%, down from 28\u00a2 per share per quarter ($1.16<\/span> per share annually) down to just 2\u00a2 per share per quarter (or 8\u00a2 per share annually).\u00a0 According to a quote attributed to Organon’s CEO, defendant Kevin Ali<\/span>, in the press release Organon issued that day, it had “reset [its] capital allocation priorities to accelerate progress towards deleveraging, enabling a path to achieve a net leverage ratio of below 4.0x by year-end,” emphasizing that Organon’s “primary capital allocation priority” was now “maintaining lower leverage.”\u00a0 On this news, the price of Organon stock fell more than 27%.<\/p>\n

The plaintiff is represented by Robbins Geller, which has extensive experience<\/a><\/b> in prosecuting investor class actions including actions involving financial fraud<\/span>.\u00a0 You can view a copy of the complaint by clicking here<\/a><\/b>.<\/p>\n

\n THE LEAD PLAINTIFF PROCESS<\/b>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Organon publicly traded securities during the Class Period to seek appointment as lead plaintiff in the Organon <\/i>class action lawsuit.\u00a0 A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.\u00a0 A lead plaintiff acts on behalf of all other class members in directing the Organon <\/i>class action lawsuit.\u00a0 The lead plaintiff can select a law firm of its choice to litigate the Organon <\/i>class action lawsuit.\u00a0 An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Organon <\/i>class action lawsuit.<\/p>\n

\n ABOUT ROBBINS GELLER<\/b>: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud<\/span> and shareholder litigation.\u00a0 Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors.\u00a0 In 2024, we recovered over $2.5 billion<\/span> for investors in securities-related class action cases \u2013 more than the next five law firms combined, according to ISS.\u00a0 With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion<\/span> \u2013 in In re Enron Corp. Sec. Litig.<\/i>\u00a0 Please visit the following page for more information:<\/p>\n

\n
\n https:\/\/www.rgrdlaw.com\/services-litigation-securities-fraud<\/span>.html<\/a>
\n <\/b>\n <\/p>\n

Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.\u00a0<\/p>\n

Contact:<\/p>\n

Robbins\u00a0Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal<\/span>
655 W. Broadway, Suite 1900, San Diego, CA<\/span> 92101
800-449-4900
info@rgrdlaw.com<\/a><\/b><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/extended-class-period-organon–co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302506018.html<\/a><\/p>\n

SOURCE Robbins Geller Rudman & Dowd LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN DIEGO , July 15, 2025 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”).\u00a0 Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon as well as certain of Organon’s top executives with violations of the Securities Exchange Act of 1934.\u00a0 A previously filed complaint is captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.). If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your information … <\/p>\n

Continue reading “EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870066","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO , July 15, 2025 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”).\u00a0 Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon as well as certain of Organon’s top executives with violations of the Securities Exchange Act of 1934.\u00a0 A previously filed complaint is captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.). If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your information … Continue reading "EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T22:19:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\",\"datePublished\":\"2025-07-15T22:19:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"},\"wordCount\":858,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2542335\\\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\",\"name\":\"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2542335\\\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg\",\"datePublished\":\"2025-07-15T22:19:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2542335\\\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2542335\\\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","og_description":"PR Newswire SAN DIEGO , July 15, 2025 \/PRNewswire\/ —\u00a0Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”).\u00a0 Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action lawsuit charges Organon as well as certain of Organon’s top executives with violations of the Securities Exchange Act of 1934.\u00a0 A previously filed complaint is captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.). If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your information … Continue reading \"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-15T22:19:11+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit","datePublished":"2025-07-15T22:19:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"},"wordCount":858,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/","name":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg","datePublished":"2025-07-15T22:19:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2542335\/robbins_geller_rudman_and_dowd_llp_logo_v2_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/extended-class-period-organon-co-ogn-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870066"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870066\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}